Canada To Trial Step-Wise Review Of Biosimilars
This article was originally published in SRA
Executive Summary
Health Canada has launched a three-year pilot to explore a step-wise review approach under which companies developing biosimilar medicines will be able to request a scientific advice meeting on their comparability package at an earlier stage to help ensure that the review proceeds as smoothly as possible1.